May 27, 2016
3 min watch
Save

VIDEO: Patients with HIV, HCV face risk for re-infection following antiviral treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Hepatitis C virus re-infection is “an enormous issue” in patients with HIV who are treated, and cured, with direct-acting antivirals, according to Vincent Lo Re, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine.

Lo Re reviews the incidence rate of re-infection, as well as the groups at highest risk and the uncertainty regarding whether insurance will pay for re-treatment of HCV. Counseling after treatment for HCV, particularly among patients who are cured, has the potential to “prevent [re-infection] from happening,” Lo Re said.

Research examining the risk factors for re-infection, which aims to help develop interventions to reduce the likelihood of its occurrence, is “going to be very important research for the future,” according to Lo Re.